Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer
1 other identifier
interventional
12
1 country
1
Brief Summary
Cancer-related cognitive problems, also known as "brain fog", have a significant impact on patients with cancer and cancer survivors. Previous studies indicate that cancer and cancer treatments can negatively affect memory, attention and thinking abilities. Adolescents and young adults (AYAs) are individuals with a cancer diagnosis, who are currently between 18 to 40 years old. These individuals are especially vulnerable to brain fog symptoms due to the effect these symptoms have on their education, employment, health behaviors, mental health, and social relationships. There is a clear need for programming directed at brain fog symptoms among AYAs with cancer diagnoses. The 'Coping with Brain Fog' program, developed by Maximum Capacity Inc., is an eight-week group program that has been designed to educate patients about their brain fog symptoms and develop strategies to manage these symptoms. In this study the investigators will aim to determine the feasibility of adapting the 'Coping with Brain Fog' program to the virtual setting for AYAs with cancer during the COVID-19 pandemic. The investigators will also aim to explore the efficacy of the program on cognitive functioning and symptoms of anxiety, depression and fatigue. This study is an important step towards finding ways to treat brain fog symptoms in cancer patients, and could help guide future studies and programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Nov 2021
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedMay 23, 2022
May 1, 2022
5 months
October 16, 2021
May 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence
The investigators will measure the adherence to the intervention by measuring attendance at the weekly sessions. The intervention will be considered feasible if 60% of participants do not miss the first two sessions and any two consecutive sessions.
Adherence will be assessed at the end of the 8-week intervention.
Participant Satisfaction - Client Satisfaction Questionnaire
The participants' satisfaction with the program will be measured using The Client Satisfaction Questionnaire (CSQ), an 8-item self-report scale which will be administered at the end of the intervention to assess the participant satisfaction. Each item on this scale is scored from 1 to 4, generating a total score ranging from 8 to 32. A total score of 8-20 indicates low satisfaction, whereas total scores of 21-26 and 27-32 indicate medium and higher satisfaction, respectively.
Participant Satisfaction will be measured at the end of the 8-week intervention.
Secondary Outcomes (6)
Perceived Cognitive Functioning - Functional Assessment of Cancer Therapy-Cognitive Function Scale
The investigators will measure perceived cognitive functioning before, one week after, and 6-8 weeks after the intervention.
Perceived Cognitive Functioning - Cancer Distress Scales for Adolescents and Young Adults
The investigators will measure perceived cognitive functioning before, one week after, and 6-8 weeks after the intervention.
Symptoms of Distress and Fatigue - Anxiety
The investigators will measure symptoms of distress before, one week after, and 6-8 weeks after the intervention.
Symptoms of Distress and Fatigue - Depression
The investigators will measure symptoms of distress before, one week after, and 6-8 weeks after the intervention.
Symptoms of Distress and Fatigue - Fatigue
The investigators will measure symptoms of distress before, one week after, and 6-8 weeks after the intervention.
- +1 more secondary outcomes
Study Arms (1)
"Coping with Brain Fog" intervention
EXPERIMENTALInterventions
The proposed intervention is an 8-week 'Coping with Brain Fog' program for cancer survivors, adapted for AYAs with cancer, with one 90-minute group session per week. The intended group size for the program is 8-12 participants. The program was developed to be delivered in person, however for the purposes of this study it will be conducted in a virtual setting. The overall goals of the program are to educate participants about cancer-related brain fog and enhance their cognitive function and wellbeing. To accomplish this, the program is segmented into three main components: memory skills, task management, and psychological wellbeing. For each component, participants are systematically introduced to evidence-based strategies to cumulatively build a repertoire of cognitive tools designed to reduce the impact of cancer-related brain fog. The program uses a manual and participant materials that are copyrighted by Maximum Capacity Inc.
Eligibility Criteria
You may qualify if:
- Age 18-40 years
- Diagnosed with any type or stage of cancer
- Seeking intervention for self-reported symptoms of brain fog (such as poor memory, mental slowness, or task insufficiency)
- Must be currently living in Manitoba, Nunavut or Northwest Ontario
- Must be able to attend eight virtual sessions of the 'Coping with Brain Fog' intervention
- Must have reliable access to the internet and the audio-visual platform Zoom
- Should also be able to read, speak and write English (as the sessions will be conducted in English)
You may not qualify if:
- Age younger than 18 or older than 40 years at the time of enrollment
- Must not have a previously diagnosed severe intellectual disability (self-reported by the participants)
- Should not be receiving any new interventions to enhance their cognitive function during the period of this study
- Must attend the first two sessions and should not miss two consecutive sessions (if a participant misses two consecutive sessions due to extenuating circumstances, they will be encouraged to withdraw from the group and be prioritized on the wait-list for the next brain fog group)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- CancerCare Manitobacollaborator
Study Sites (1)
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
Related Publications (12)
Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive Changes in Cancer Survivors. Am Soc Clin Oncol Educ Book. 2018 May 23;38:795-806. doi: 10.1200/EDBK_201179.
PMID: 30231372BACKGROUNDJean-Pierre P, Winters PC, Ahles TA, Antoni M, Armstrong FD, Penedo F, Lipshultz SE, Miller TL, Fiscella K. Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract. 2012 Jan;8(1):30-4. doi: 10.1200/JOP.2011.000231. Epub 2011 Nov 22.
PMID: 22548008BACKGROUNDPrasad PK, Hardy KK, Zhang N, Edelstein K, Srivastava D, Zeltzer L, Stovall M, Seibel NL, Leisenring W, Armstrong GT, Robison LL, Krull K. Psychosocial and Neurocognitive Outcomes in Adult Survivors of Adolescent and Early Young Adult Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Aug 10;33(23):2545-52. doi: 10.1200/JCO.2014.57.7528. Epub 2015 Jul 6.
PMID: 26150441BACKGROUNDMcDougall GJ Jr, Oliver JS, Scogin F. Memory and cancer: a review of the literature. Arch Psychiatr Nurs. 2014 Jun;28(3):180-6. doi: 10.1016/j.apnu.2013.12.005. Epub 2014 Mar 22.
PMID: 24856270BACKGROUNDAhles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol. 2012 Oct 20;30(30):3675-86. doi: 10.1200/JCO.2012.43.0116. Epub 2012 Sep 24.
PMID: 23008308BACKGROUNDBarnett M, McDonnell G, DeRosa A, Schuler T, Philip E, Peterson L, Touza K, Jhanwar S, Atkinson TM, Ford JS. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016 Oct;10(5):814-31. doi: 10.1007/s11764-016-0527-6. Epub 2016 Feb 26.
PMID: 26920873BACKGROUNDPerales MA, Drake EK, Pemmaraju N, Wood WA. Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer. Curr Hematol Malig Rep. 2016 Dec;11(6):449-455. doi: 10.1007/s11899-016-0313-6.
PMID: 26893061BACKGROUNDAnderson C, Nichols HB. Trends in Late Mortality Among Adolescent and Young Adult Cancer Survivors. J Natl Cancer Inst. 2020 Oct 1;112(10):994-1002. doi: 10.1093/jnci/djaa014.
PMID: 32123906BACKGROUNDMiller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020 Nov;70(6):443-459. doi: 10.3322/caac.21637. Epub 2020 Sep 17.
PMID: 32940362BACKGROUNDLarsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available.
PMID: 10245370BACKGROUNDTsangaris E, D'Agostino N, Rae C, Breakey V, Klassen AF. Development and Psychometric Evaluation of the Cancer Distress Scales for Adolescent and Young Adults. J Adolesc Young Adult Oncol. 2019 Oct;8(5):566-580. doi: 10.1089/jayao.2019.0005. Epub 2019 Jul 8.
PMID: 31274372BACKGROUNDMuthumuni D, Scott I, Chochinov HM, Mahar AL, Garland SN, Schulte F, Lambert P, Lix L, Garland A, Oberoi S. Feasibility and Acceptability of a Virtual "Coping with Brain Fog" Intervention for Improving Cognitive Functioning in Young Adults with Cancer. J Adolesc Young Adult Oncol. 2023 Oct;12(5):662-673. doi: 10.1089/jayao.2023.0022. Epub 2023 May 8.
PMID: 37158780DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Hematologist Oncologist
Study Record Dates
First Submitted
October 16, 2021
First Posted
November 10, 2021
Study Start
November 1, 2021
Primary Completion
March 31, 2022
Study Completion
October 31, 2022
Last Updated
May 23, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share